The DOI matches its Crossref record.
HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ Hybridization
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
Xing, Y., Chaudry, Q., Shen, C., Kong, K. Y., Zhau, H. E., Chung, L. W., Petros, J. A., O'Regan, R. M., Yezhelyev, M. V., Simons, J. W., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.107 · Cited by 528
Mass, R. D., Press, M. F., Anderson, S., Cobleigh, M. A., Vogel, C. L., Dybdal, N., Leiberman, G., & Slamon, D. J. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.026 · Cited by 359
EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus
Hanawa, M., Suzuki, S., Dobashi, Y., Yamane, T., Kono, K., Enomoto, N., & Ooi, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21454 · Cited by 298
Current Perspectives on HER2 Testing: A Review of National Testing Guidelines
Bilous, M., Dowsett, M., Hanna, W., Isola, J., Lebeau, A., Moreno, A., Penault-Llorca, F., Rüschoff, J., Tomasic, G., & van de Vijver, M. (2003) · Modern Pathology · doi:10.1097/01.mp.0000052102.90815.82 · Cited by 264
Artificial intelligence in digital breast pathology: Techniques and applications
Ibrahim, A., Gamble, P., Jaroensri, R., Abdelsamea, M. M., Mermel, C. H., Chen, P.-H. C., & Rakha, E. A. (2020) · The Breast · doi:10.1016/j.breast.2019.12.007 · Cited by 202
“Although this approach is wellvalidated and widely used, there is significant inter-observer variability in manual biomarker status assessment from IHC [45,46] suggesting an opportunity for machine-learning based systems to assist pathologists with biomarker status assessments.”
BackgroundInfluential
Metadata
- Authors
- Thomson, T. A., Hayes, M. M., Spinelli, J. J., Hilland, E., Sawrenko, C., Phillips, D., Dupuis, B., & Parker, R. L.
- Venue
- Modern Pathology
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 14
- Issue
- 11
- Pages
- 1079-1086
- ISSN
- 0893-3952 (ISSN-L)
- OpenAlex
- W2072648072
- Cited by
- 214
- References
- 0
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.